T

Tongling Jieya Biologic Technology Co Ltd
SZSE:301108

Watchlist Manager
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Watchlist
Price: 28.1 CNY -0.64% Market Closed
Market Cap: 2.3B CNY
Have any thoughts about
Tongling Jieya Biologic Technology Co Ltd?
Write Note

Tongling Jieya Biologic Technology Co Ltd
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Tongling Jieya Biologic Technology Co Ltd
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
T
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Long-Term Debt
ÂĄ9.6m
CAGR 3-Years
22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Long-Term Debt
ÂĄ2.4B
CAGR 3-Years
11%
CAGR 5-Years
-11%
CAGR 10-Years
-5%
Proya Cosmetics Co Ltd
SSE:603605
Long-Term Debt
ÂĄ781.9m
CAGR 3-Years
N/A
CAGR 5-Years
86%
CAGR 10-Years
N/A
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Long-Term Debt
ÂĄ68m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Long-Term Debt
ÂĄ161.5m
CAGR 3-Years
4%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Long-Term Debt
ÂĄ1.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Tongling Jieya Biologic Technology Co Ltd
Glance View

Market Cap
2.3B CNY
Industry
Consumer products

Tongling Jieya Biologic Technology Co., Ltd. engages in the research and development, production, and sale of wet wipes. The company is headquartered in Tongling, Anhui and currently employs 798 full-time employees. The company went IPO on 2021-12-03. The firm's main businesses are the research and development, production and sales of sanitary products. The firm's wet wipes products include baby series, adult functional series, antibacterial disinfection series, household cleaning series, medical care series and pet cleaning series. The firm is also engaged in the production of facial masks.

Intrinsic Value
22.97 CNY
Overvaluation 18%
Intrinsic Value
Price
T

See Also

What is Tongling Jieya Biologic Technology Co Ltd's Long-Term Debt?
Long-Term Debt
9.6m CNY

Based on the financial report for Dec 31, 2023, Tongling Jieya Biologic Technology Co Ltd's Long-Term Debt amounts to 9.6m CNY.

What is Tongling Jieya Biologic Technology Co Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 3Y
22%

Over the last year, the Long-Term Debt growth was -48%. The average annual Long-Term Debt growth rates for Tongling Jieya Biologic Technology Co Ltd have been 22% over the past three years .

Back to Top